Save time and get answers to complex questions with AI chat
Drugpatentwatch trametinib?Combivent generic equivalent?When genetic tenofovir alafenamide be available in us?How to apply for vascepa's patient assistance?Quartette side effects?
NCT04502433 is listed as a clinical trial involving poractant alfa (a pulmonary surfactant). The trial title is: “Poractant Alfa in the Prevention of Bronchopulmonary Dysplasia in Preterm Infants”.
The study focuses on testing poractant alfa in preterm infants, with an aim tied to reducing the risk of bronchopulmonary dysplasia (BPD).
You can verify the exact wording and other record details directly in the trial registry entry for NCT04502433 (ClinicalTrials.gov). Sources: 1. https://clinicaltrials.gov/ct2/show/NCT04502433
Other Questions About Poractant :